Ven Bio Partners LLC Harmony Biosciences Holdings, Inc. Transaction History

Ven Bio Partners LLC

  • $93.4 Million
  • Q1 2025

A detailed history of Ven Bio Partners LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ven Bio Partners LLC holds 489,194 shares of HRMY stock, worth $17.3 Million. This represents 17.38% of its overall portfolio holdings.

Number of Shares
489,194
Previous 539,194 9.27%
Holding current value
$17.3 Million
Previous $18.6 Million 12.49%
% of portfolio
17.38%
Previous 15.27%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$32.18 - $40.46 $1.61 Million - $2.02 Million
-50,000 Reduced 9.27%
489,194 $16.2 Million
Q4 2024

Feb 14, 2025
SELL
$31.86 - $41.49 $2.4 Million - $3.13 Million
-75,400 Reduced 12.27%
539,194 $18.6 Million
Q3 2024

Nov 14, 2024
SELL
$30.0 - $39.95 $12.6 Million - $16.8 Million
-420,802 Reduced 40.64%
614,594 $24.6 Million
Q4 2022

Feb 14, 2023
SELL
$45.4 - $60.91 $4.1 Million - $5.5 Million
-90,277 Reduced 8.02%
1,035,396 $57.1 Million
Q3 2022

Nov 14, 2022
SELL
$42.06 - $55.45 $13.6 Million - $17.9 Million
-323,047 Reduced 22.3%
1,125,673 $49.9 Million
Q2 2022

Aug 15, 2022
SELL
$33.54 - $52.15 $3.21 Million - $4.99 Million
-95,764 Reduced 6.2%
1,448,720 $70.7 Million
Q1 2022

May 16, 2022
SELL
$33.14 - $51.13 $39.6 Million - $61.1 Million
-1,195,927 Reduced 43.64%
1,544,484 $75.1 Million
Q4 2021

Feb 14, 2022
SELL
$34.09 - $43.91 $11 Million - $14.2 Million
-322,783 Reduced 10.54%
2,740,411 $117 Million
Q3 2021

Nov 15, 2021
SELL
$25.68 - $38.61 $11.3 Million - $17 Million
-441,430 Reduced 12.6%
3,063,194 $117 Million
Q3 2020

Nov 16, 2020
BUY
$30.96 - $44.39 $109 Million - $156 Million
3,504,624 New
3,504,624 $119 Million

Others Institutions Holding HRMY

# of Institutions
283
Shares Held
44.8M
Call Options Held
130K
Put Options Held
46.5K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.1B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Ven Bio Partners LLC Portfolio

Follow Ven Bio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ven Bio Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email